Taken together, we support that adipocytes in the tumor microenvironment induce breast cancer progression through activating the PI3K-AKT-mTOR signaling pathway, suggesting inhibition of dual target such as PI3K and mTOR as a potentially good option for developing a novel targeted therapy for breast cancer. The gene discussed is AKT1; the disease is breast cancer.